SFSimon FletcherPhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021TLR-8 Agonist - S. Fletcher, PhDView Slideset
AGAdam GehringPhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021What Can We Learn by Deploying Immunological Analysis in Phase II Clinical Trials - A. Gehring, PhDView Slideset
FZFabien ZoulimMD, PhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Patient Selection for Clinical Trials Based on Drug Class - F. Zoulim, MD, PhDView Slideset
PLPietro LamperticoMD, PhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021New Data From Combination Trials for Chronic Hepatitis B - P. Lampertico, MD, PhDView Slideset
JSGJeffrey S. GlennMD, PhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021New Combination Therapies in Hepatitis Delta Therapy - J. Glenn, MD, PhDView Slideset
DMDmitry ManuilovMDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Update on the Efficacy and Safety of Bulevirtide for Treatment of Chronic HDV - D. Manuilov, MDView Video
DMDouglas MayersMDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Active Site Polymerase Inhibitor Nucleotides (APSINs) - D. Mayers, MDView Video
MMMatthew McClureMDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021STOP Agents - M. McClure, MDView Video
LFLeigh FeltonBSc, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Antisense Oligos - L. Felton, BSc, PhDView Video
LSLuisa StammMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Core Inhibitors (Capsid Assembly Modulators) - L. Stamm, MD, PhDView Video
SUStephan UrbanPhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Biological Insights Taught by Clinical Responses to Novel Hbv/Hdv Drugs - S. Urban, PhDView Video
PMPoonam MishraMD, MPH, FAASLDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Safety Monitoring during HBV Clinical Trials and after Antiviral Discontinuation -P. Mishra, MDView Video
